– CNBC
Veterans With ALS Who Support Co’s Request For The FDA To Hold A Public Advisory Committee Meeting To Engage In Scientific Discourse About The “Clinically Meaningful” Evidence Supporting FDA’s Approval Of A Mesenchymal Stem Cell Therapy, NurOwn
Veterans have a Significantly Increased Risk of 100% Fatal ALS, Caused by their Service for our Country
FDA Advisory Committee Meeting is Essential to Allow Veterans' Voices to be Heard about Need for
